ImmunOs Therapeutics raises $74M
ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune…
ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune…
US regulators have approved the first-in-class drug efgartigimod for the treatment of the rare muscle…
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their…
An antibody drug developed by the Irish biopharma Horizon Therapeutics has been approved by the…
ImCheck Therapeutics has raised a Series B round worth €48M to fund the development of…
The Dutch biotech argenx, which develops antibody drugs to treat autoimmune diseases and cancer, has…
Public and private organizations across Europe will pool their resources in an €80M project to…
We come to the biotech hub of Paris, France, where the biotech Ermium Therapeutics is…
MiroBio has spun out of the University of Oxford with a Series A round of…
Many biotech founders and executives look to VC investors for advice and inspiration, but the…